Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)
CNY 2.95
(4.24%)
CNY 2.95
(4.24%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 948.69 Million CNY | -44.43% |
| 2022 | 1.6 Billion CNY | -42.76% |
| 2021 | 2.8 Billion CNY | -17.05% |
| 2020 | 3.38 Billion CNY | -19.98% |
| 2019 | 4.22 Billion CNY | 15.72% |
| 2018 | 3.65 Billion CNY | 52.71% |
| 2017 | 2.39 Billion CNY | 69.01% |
| 2016 | 1.41 Billion CNY | 117.92% |
| 2015 | 648.99 Million CNY | 71.28% |
| 2014 | 378.9 Million CNY | 60.4% |
| 2013 | 236.22 Million CNY | 41.28% |
| 2012 | 167.2 Million CNY | 44.12% |
| 2011 | 116.01 Million CNY | 51.21% |
| 2010 | 76.72 Million CNY | 30.46% |
| 2009 | 58.8 Million CNY | 25.52% |
| 2008 | 46.85 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 228.26 Million CNY | 38.96% |
| 2024 Q1 | 191.91 Million CNY | 41.67% |
| 2024 Q2 | 197.6 Million CNY | 2.97% |
| 2023 Q3 | 255.49 Million CNY | -12.91% |
| 2023 Q4 | 135.46 Million CNY | -46.98% |
| 2023 FY | 891.8 Million CNY | -44.43% |
| 2023 Q1 | 207.47 Million CNY | -7.02% |
| 2023 Q2 | 293.36 Million CNY | 41.39% |
| 2022 Q3 | 465.09 Million CNY | 2.27% |
| 2022 Q4 | 223.13 Million CNY | -52.02% |
| 2022 FY | 1.6 Billion CNY | -42.76% |
| 2022 Q1 | 461.97 Million CNY | -23.45% |
| 2022 Q2 | 454.76 Million CNY | -1.56% |
| 2021 FY | 2.8 Billion CNY | -17.05% |
| 2021 Q2 | 709.84 Million CNY | -7.43% |
| 2021 Q3 | 723.78 Million CNY | 1.96% |
| 2021 Q4 | 603.5 Million CNY | -16.62% |
| 2021 Q1 | 766.84 Million CNY | -19.38% |
| 2020 Q4 | 951.15 Million CNY | 2.7% |
| 2020 Q3 | 926.14 Million CNY | 10.3% |
| 2020 FY | 3.38 Billion CNY | -19.98% |
| 2020 Q1 | 663.39 Million CNY | -37.48% |
| 2020 Q2 | 839.67 Million CNY | 26.57% |
| 2019 Q2 | 1.07 Billion CNY | 11.39% |
| 2019 Q3 | 1.12 Billion CNY | 5.2% |
| 2019 FY | 4.22 Billion CNY | 15.72% |
| 2019 Q1 | 962.65 Million CNY | 1.08% |
| 2019 Q4 | 1.06 Billion CNY | -5.93% |
| 2018 Q3 | 1 Billion CNY | 7.72% |
| 2018 FY | 3.65 Billion CNY | 52.71% |
| 2018 Q4 | 952.35 Million CNY | -5.53% |
| 2018 Q2 | 935.85 Million CNY | 24.13% |
| 2018 Q1 | 753.92 Million CNY | 10.97% |
| 2017 FY | 2.39 Billion CNY | 69.01% |
| 2017 Q3 | 652.93 Million CNY | 16.91% |
| 2017 Q4 | 679.42 Million CNY | 4.06% |
| 2017 Q2 | 558.49 Million CNY | 11.82% |
| 2017 Q1 | 499.43 Million CNY | 6.92% |
| 2016 FY | 1.41 Billion CNY | 117.92% |
| 2016 Q2 | 332.63 Million CNY | 46.23% |
| 2016 Q3 | 387.06 Million CNY | 16.37% |
| 2016 Q4 | 467.12 Million CNY | 20.68% |
| 2016 Q1 | 227.46 Million CNY | 4.57% |
| 2015 Q2 | 156.52 Million CNY | 62.66% |
| 2015 Q3 | 178.72 Million CNY | 14.18% |
| 2015 Q4 | 217.51 Million CNY | 21.7% |
| 2015 FY | 648.99 Million CNY | 71.28% |
| 2015 Q1 | 96.22 Million CNY | -30.33% |
| 2014 Q3 | 95.95 Million CNY | 6.85% |
| 2014 Q2 | 89.79 Million CNY | 63.15% |
| 2014 Q1 | 55.03 Million CNY | -20.2% |
| 2014 FY | 378.9 Million CNY | 60.4% |
| 2014 Q4 | 138.11 Million CNY | 43.94% |
| 2013 Q2 | 62.46 Million CNY | 52.88% |
| 2013 FY | 236.22 Million CNY | 41.28% |
| 2013 Q4 | 68.97 Million CNY | 7.87% |
| 2013 Q3 | 63.93 Million CNY | 2.37% |
| 2013 Q1 | 40.85 Million CNY | -16.66% |
| 2012 Q4 | 49.02 Million CNY | 10.57% |
| 2012 Q3 | 44.33 Million CNY | 14.9% |
| 2012 Q2 | 38.58 Million CNY | 9.46% |
| 2012 Q1 | 35.25 Million CNY | -3.0% |
| 2012 FY | 167.2 Million CNY | 44.12% |
| 2011 FY | 116.01 Million CNY | 51.21% |
| 2011 Q3 | 34.62 Million CNY | 51.54% |
| 2011 Q2 | 22.84 Million CNY | 2.91% |
| 2011 Q1 | 22.2 Million CNY | 5.63% |
| 2011 Q4 | 36.34 Million CNY | 4.97% |
| 2010 Q2 | 20.08 Million CNY | 37.35% |
| 2010 Q4 | 21.01 Million CNY | -0.0% |
| 2010 FY | 76.72 Million CNY | 30.46% |
| 2010 Q1 | 14.62 Million CNY | 0.0% |
| 2010 Q3 | 21.01 Million CNY | 4.65% |
| 2009 FY | 58.8 Million CNY | 25.52% |
| 2008 FY | 46.85 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| China National Accord Medicines Corporation Ltd. | 6.58 Billion CNY | 85.592% |
| Shenzhen Glory Medical Co.,Ltd. | 276.22 Million CNY | -243.448% |